Cash Conversion

Cash Conversion

Figures converted from CNY at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

TBEA spent $3.15bn of capex against $1.33bn of operating cash in FY2025, pushing free cash flow to -$1.82bn, a third straight year of decline; the spend has rotated from the completed polysilicon plant into a $2.43bn coal-to-gas project and a $0.97bn alumina build, part-funded by $0.66bn of fresh cash from subsidiaries' minority shareholders rather than TBEA's own. [1][2] Reported profit still converts to operating cash — cumulative operating cash flow over FY2022–FY2025 ran about 1.9 times net income, so this is not an accruals story. What has changed is the capital-spending programme one line below it, now running at 2.4 times operating cash flow.

The free-cash deficit is a choice, not a distress signal. Depreciation and amortization of about $0.93bn (derived from reported financials) marks a rough floor for maintenance spending, so most of the $3.15bn is discretionary growth capital, and free cash flow recovers the year the coal-to-gas and alumina builds finish. Net debt of about $2.37bn, roughly 22% of equity, set against $3.67bn of cash [3], leaves room to carry the spend in the meantime. The main risk is duration: capex staying above $2.9bn for another two or three years while coal and polysilicon margins stay depressed.

Sources: FY2025 Annual Report, Consolidated Statement of Cash Flows [4]; net debt and ratios derived from reported financials, FY2022–FY2025.

Earnings convert to operating cash; capex takes it all

The accrual test comes out clean. In each of the last four years operating cash flow exceeded net income — by 1.4x in the FY2022 peak, and by more than 3x in the depressed FY2024 as depreciation and working-capital release cushioned a thin profit. Cumulatively, $9.9bn of operating cash against $5.2bn of attributable profit is a conversion rate a skeptic cannot fault at the earnings-quality level.

Source: derived from reported financials, FY2022–FY2025 annual reports; FY2025 and FY2024 cash flows per the Consolidated Statement of Cash Flows [5] and FY2023/FY2022 per the FY2023 report [6].

The free-cash line tells the opposite story. Operating cash flow fell from $3.63bn in FY2023 to $1.77bn in FY2024 and $1.33bn in FY2025 [7][8], even as attributable profit rose in FY2025. Capital expenditure moved the other way — to $3.15bn, its highest in the window [9]. Free cash flow has gone from +$0.97bn to -$0.59bn to -$1.82bn.

Sources: FY2025 Annual Report, Consolidated Statement of Cash Flows [10]; FY2023 Annual Report [11].

The capital is now going into the $2.43bn coal-to-gas and $0.97bn alumina builds still running (Coal and Power), the polysilicon nameplate now complete (Polysilicon). Until those builds finish, the businesses funding them are earning less than they were — the same coal and polysilicon margins that fell in the prior chapters.

The working-capital build under the cash line

Part of the operating-cash decline is a balance sheet that has absorbed cash as the order book grew. Trade receivables rose to $2.79bn from $1.87bn in FY2022 — a 51% increase against essentially flat revenue [12]. Inventory climbed the same 51%, to $3.06bn [13]. On top of that sit $0.94bn of contract assets — engineering revenue recognized on a percentage-of-completion basis but not yet billed, including frontier-market projects in Tanzania and Uganda whose settlement conditions are not yet met [14].

Source: FY2025 Annual Report, Consolidated Balance Sheet [15]; FY2022–FY2023 balances from reported financials, as reported.

Counting notes receivable ($0.24bn), receivable-financing balances ($0.52bn), trade receivables and contract assets together, roughly $4.4bn of the group's cash is tied up in what customers and projects owe it [16]. Some of that build is genuine growth in the grid and export franchise (The Grid Franchise); part is the slower collection that comes with a larger share of frontier-market turnkey work.

How operating cash is held up

The mechanism behind operating cash is worth stating directly: TBEA monetizes its receivable book rather than waiting on it. In FY2025 it endorsed or discounted $0.53bn of bank-acceptance notes with full derecognition — moved off the balance sheet, pulling their cash forward into operations [17]. It ran a further $0.24bn of bill-discount borrowing [18], and one of its FY2025 bond issues earmarked $100m of proceeds specifically to fund a supply-chain factoring book for its trading partners [19].

None of this is improper — bank-acceptance-note discounting is routine for a Chinese industrial, and the amount has actually shrunk from about $0.84bn at the FY2022 peak. But it is a lever with a ceiling: operating cash is being supported by turning receivables into cash faster, not by the underlying businesses generating more of it. The reported $1.33bn of operating cash is modestly flattered by financing-adjacent activity, not understated.

Who funds the gap

With free cash flow at -$1.82bn and the dividend still being paid, the shortfall is covered from three places. The group took on net new debt of about $1.29bn — $3.87bn of borrowings plus $0.21bn of bonds against $2.79bn repaid [20]. It drew $0.66bn of fresh cash from minority shareholders of its subsidiaries — outside investors putting money directly into Xinte and the energy arms rather than into TBEA itself [21]. The balance came from running down cash, which fell $0.36bn to $3.67bn [22].

Source: FY2025 Annual Report, Consolidated Statement of Cash Flows [23].

The minority-injection line is the same structure the polysilicon chapter flagged from the other side: TBEA consolidates 100% of Xinte's debt and capex but owns two-thirds of its equity (The Polysilicon Engine). On the funding side, that asymmetry works in TBEA holders' favour — outside shareholders financed $0.66bn of the group's capital programme in FY2025, against $0.09bn a year earlier. It is real capital, but it is not TBEA's, and it comes with a claim on a third of the subsidiaries' future cash.

The dividend, the equity, and the leverage

Two clarifications matter for judging balance-sheet resilience. First, the share count. Weighted shares jumped from about 4.48bn to 5.05bn between FY2023 and FY2024, which reads like an equity raise into the capex. It was not: paid-in share capital rose from 3.885bn to 5.053bn shares (at ¥1 par) between end-FY2022 and end-FY2023, matched by a reduction in capital reserve — a capitalization of reserves that raised no cash and diluted no one proportionally [24][25]. The $3.15bn capex was funded by debt and internal and minority cash, not by selling new shares to the public.

Second, the dividend is held to a set share of profit rather than defended at all costs. The FY2025 distribution is $0.051 per share, $0.26bn in total, pegged at 30.35% of attributable profit [26] — the same 30% ratio as FY2024, and well below the 64% three-year cumulative payout the group ran through the higher-earning years [27]. Management is conserving cash, not stretching to sustain a headline yield. Against that, $0.57bn of perpetual bonds sit inside reported equity of $10.63bn — securities that carry coupons and behave like debt, so a stricter lens would nudge leverage up by that amount [28].

Net debt roughly doubled in a year, from $1.14bn to $2.37bn, and total borrowings — long-term loans, bonds and leases — reached about $6.0bn from $4.0bn in FY2022 (derived from reported financials). At 22% of equity, net leverage is not yet a concern; against $3.67bn of cash [29] and a debt-to-equity ratio near 0.57, the group can carry the current spend. The condition that would change that read is duration: if capex stays above $2.9bn for another two or three years while coal and polysilicon margins hold at today's depressed levels, the funding mix leans harder on debt and minority capital, and the balance-sheet cushion that looks comfortable now thins out.

Consensus expects revenue to grow about 10% in FY2026, to roughly $15.3bn. Faster top-line growth does not, on its own, close a cash gap driven by capital intensity and margin — it is the capex decision and the coal and polysilicon price path, not the revenue line, that determine when free cash flow turns positive again.